RAYMOND JAMES & ASSOCIATES - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 20 filers reported holding VASCULAR BIOGENICS LTD in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2021$26,000
-13.3%
12,6760.0%0.00%
Q2 2021$30,000
+30.4%
12,676
+8.3%
0.00%
Q1 2021$23,000
+15.0%
11,700
+9.3%
0.00%
Q4 2020$20,000
-39.4%
10,700
-60.7%
0.00%
Q3 2020$33,000
-23.3%
27,250
-18.4%
0.00%
Q2 2020$43,000
-4.4%
33,4000.0%0.00%
Q1 2020$45,000
+9.8%
33,400
-2.9%
0.00%
Q4 2019$41,000
-22.6%
34,400
-12.7%
0.00%
Q3 2019$53,000
-25.4%
39,400
-27.6%
0.00%
Q2 2019$71,000
-14.5%
54,4000.0%0.00%
Q1 2019$83,000
+56.6%
54,4000.0%0.00%
Q4 2018$53,000
-62.7%
54,400
-37.6%
0.00%
Q3 2018$142,000
-21.5%
87,142
+6.1%
0.00%
Q2 2018$181,000
-4.7%
82,142
-11.8%
0.00%
Q1 2018$190,000
-51.8%
93,142
+67.9%
0.00%
-100.0%
Q4 2017$394,000
+100.0%
55,466
+71.5%
0.00%
Q3 2017$197,000
+9.4%
32,342
-19.8%
0.00%
Q2 2017$180,000
+119.5%
40,342
+171.5%
0.00%
Q1 2017$82,000
+24.2%
14,857
+17.4%
0.00%
Q3 2016$66,00012,6570.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$4,382,0001.02%
Telemetry Investments, L.L.C. 75,000$127,0000.20%
Ikarian Capital, LLC 830,747$1,404,0000.18%
DLD Asset Management, LP 550,000$930,0000.06%
Phoenix Holdings Ltd. 1,020,000$1,724,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$27,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$135,0000.00%
HBK Sorce Advisory LLC 22,325$38,0000.00%
B. Riley Wealth Management, Inc. 12,000$20,0000.00%
TWO SIGMA SECURITIES, LLC 12,155$21,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders